96 related articles for article (PubMed ID: 1565644)
1. Cloning and expression of the tumor-associated antigen L6.
Marken JS; Schieven GL; Hellström I; Hellström KE; Aruffo A
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3503-7. PubMed ID: 1565644
[TBL] [Abstract][Full Text] [Related]
2. TM4SF1: a new vascular therapeutic target in cancer.
Lin CI; Merley A; Sciuto TE; Li D; Dvorak AM; Melero-Martin JM; Dvorak HF; Jaminet SC
Angiogenesis; 2014 Oct; 17(4):897-907. PubMed ID: 24986520
[TBL] [Abstract][Full Text] [Related]
3. [Construction of a eukaryotic expression vector of TM4SF1 and its effect on migration and invasion of colorectal cancer cells].
Wang D; Chen N; Peng M; Xu Q; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):847-51. PubMed ID: 24968843
[TBL] [Abstract][Full Text] [Related]
4. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration.
Xu L; Li Q; Xu D; Wang Q; An Y; Du Q; Zhang J; Zhu Y; Miao Y
Int J Oncol; 2014 Feb; 44(2):459-66. PubMed ID: 24285464
[TBL] [Abstract][Full Text] [Related]
5. TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration.
Allioli N; Vincent S; Vlaeminck-Guillem V; Decaussin-Petrucci M; Ragage F; Ruffion A; Samarut J
Prostate; 2011 Aug; 71(11):1239-50. PubMed ID: 21656834
[TBL] [Abstract][Full Text] [Related]
6. The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis.
Shih SC; Zukauskas A; Li D; Liu G; Ang LH; Nagy JA; Brown LF; Dvorak HF
Cancer Res; 2009 Apr; 69(8):3272-7. PubMed ID: 19351819
[TBL] [Abstract][Full Text] [Related]
7. Identification of marker genes for spinal cord injury.
Luan Z; Zhang J; Wang Y
Front Med (Lausanne); 2024; 11():1364380. PubMed ID: 38463490
[TBL] [Abstract][Full Text] [Related]
8. TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells.
Kitajima H; Maruyama R; Niinuma T; Yamamoto E; Takasawa A; Takasawa K; Ishiguro K; Tsuyada A; Suzuki R; Sudo G; Kubo T; Mitsuhashi K; Idogawa M; Tange S; Toyota M; Yoshido A; Kumegawa K; Kai M; Yanagihara K; Tokino T; Osanai M; Nakase H; Suzuki H
Cell Death Dis; 2023 Jul; 14(7):424. PubMed ID: 37443145
[TBL] [Abstract][Full Text] [Related]
9. Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance.
Rahim NS; Wu YS; Sim MS; Velaga A; Bonam SR; Gopinath SCB; Subramaniyan V; Choy KW; Teow SY; Fareez IM; Samudi C; Sekaran SD; Sekar M; Guad RM
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678607
[TBL] [Abstract][Full Text] [Related]
10. A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor Immunity.
Sher YP; Chai KM; Chen WC; Shen KY; Chen IH; Lee MH; Chiu FF; Liu SJ
Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33096846
[TBL] [Abstract][Full Text] [Related]
11. Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer.
Fu F; Yang X; Zheng M; Zhao Q; Zhang K; Li Z; Zhang H; Zhang S
Front Mol Biosci; 2020; 7():202. PubMed ID: 33015133
[TBL] [Abstract][Full Text] [Related]
12. Expression, Location, Clinical Implication, and Bioinformatics Analysis of RNASET2 in Gastric Adenocarcinoma.
Zeng Z; Zhang X; Li D; Li J; Yuan J; Gu L; Xiong X
Front Oncol; 2020; 10():836. PubMed ID: 32528897
[No Abstract] [Full Text] [Related]
13. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
[No Abstract] [Full Text] [Related]
14. Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine.
Sher YP; Lin SI; Chai KM; Chen IH; Liu SJ
Am J Cancer Res; 2019; 9(9):2028-2036. PubMed ID: 31598403
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-206 inhibits metastasis of triple-negative breast cancer by targeting transmembrane 4 L6 family member 1.
Fan C; Liu N; Zheng D; Du J; Wang K
Cancer Manag Res; 2019; 11():6755-6764. PubMed ID: 31413629
[No Abstract] [Full Text] [Related]
16. Phage display screening of therapeutic peptide for cancer targeting and therapy.
Saw PE; Song EW
Protein Cell; 2019 Nov; 10(11):787-807. PubMed ID: 31140150
[TBL] [Abstract][Full Text] [Related]
17. Two Proximally Close Priority Candidate Genes for diplopodia-1, an Autosomal Inherited Craniofacial-Limb Syndrome in the Chicken: MRE11 and GPR83.
O'Hare EA; Antin PB; Delany ME
J Hered; 2019 Mar; 110(2):194-210. PubMed ID: 30597046
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
20. Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor.
Zacharias WJ; Frank DB; Zepp JA; Morley MP; Alkhaleel FA; Kong J; Zhou S; Cantu E; Morrisey EE
Nature; 2018 Mar; 555(7695):251-255. PubMed ID: 29489752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
